AnalystsSami CorwinSami Corwin's Stock Forecasts
AnalystsSami Corwin
Sectors:
Industries:
Analyst Ranking
Bottom 15%
#4711 out of 5510 analysts
Average Return
-5.36%
Win Rate
20%2 out of 10
Risk vs Reward
Poor
Good
Sami Corwin's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Kyverna Therapeutics IncKYTX | +158.60% | $3.43 | $8.87 | 2025-08-20 - 2026-08-19 | Buy |
Akouos IncAKUS | +110.32% | $6.30 | $13.25 | 2022-09-29 - 2022-10-19 | Buy |
Sami Corwin Analyst Color
Get additional color on Sami Corwin's coverage of popular stocks
Sami Corwin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Obsidian Therapeutics IncOBX | 1 | Buy | N/A | N/A | Initiates Coverage On | 6 days ago |
Ultragenyx Pharmaceutical IncRARE | 2 | Hold | N/A | N/A | Downgrades | 12 days ago |
Uniqure NvQURE | 3 | Buy | N/A | N/A | Reinstates | 13 days ago |
Kyverna Therapeutics IncKYTX | 1 | Buy | N/A | N/A | Initiates Coverage On | a year ago |
Sarepta Therapeutics IncSRPT | 1 | Hold | N/A | N/A | Downgrades | a year ago |
Nkarta IncNKTX | 1 | Hold | N/A | N/A | Downgrades | a year ago |
Cargo Therapeutics IncCRGX | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Applied Therapeutics IncAPLT | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Tenaya Therapeutics IncTNYA | 1 | Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Neurogene IncNGNE | 1 | Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Mesoblast LtdMESO | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Crispr Therapeutics AgCRSP | 1 | Buy | $75.00 | N/A | Reinstates | 3 years ago |
Legend Biotech CorpLEGN | 1 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Akouos IncAKUS | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.